Debates exist regarding the merit of starting one dialysis modality over the other for improved cardiovascular outcomes. Five previously published prospective and retrospective cohort studies have reported inconsistent conclusions on this topic. The aim of this systematic review and meta-analysis is to evaluate the influence initiation of hemodialysis (HD) vs peritoneal dialysis (PD) may have on the relative risk (RR) of subsequent development of adverse cardiovascular events (ACVE) in patients with end-stage renal disease (ESRD). Of the 518 records identified, 5 cohort studies, assessing a total of 47,062 patients were included in the meta-analysis. With regard to the subsequent development of ACVE following initiation on the different dialysis modalities, the pooled RR was found to be non-significant. Peritoneal dialysis is a suitable and cost-effective alternative to HD for ESRD patients at risk of cardiovascular disease.
WangI.K., LuC.Y., LinC.L., LiangC.C., YenT.H., LiuY.L.Comparison of the risk of de novo cardiovascular disease between hemodialysis and peritoneal dialysis in patients with end-stage renal disease.Int J Cardiol2016; 218: 219–24.
2.
RefaatH., SanyD., MohabA., EzzatH.Comparing dialysis modality and cardiovascular mortality in patients on hemodialysis and peritoneal dialysis.Adv Perit Dial2016; 32: 22–31.
3.
GaneshS.K., Hulbert-ShearonT., PortF.K., EagleK., StackA.G.Mortality differences by dialysis modality among incident ESRD patients with and without coronary artery disease.J Am Soc Nephrol2003; 14: 415–24.
4.
CourivaudC., KazoryA., CrépinT., AzarR., Bresson-VautrinC., ChalopinJ.M.Peritoneal dialysis reduces the number of hospitalization days in heart failure patients refractory to diuretics.Perit Dial Int2014; 34(1): 100–8.
5.
KwanB.C., SzetoC.C.Is peritoneal dialysis kinder for the heart?Perit Dial Int 201; 31(2): 135–7.
6.
WoodrowG.Volume status in peritoneal dialysis.Perit Dial Int2011; 31(Suppl 2): S77–82.
7.
McIntyreC.W.Hemodynamic effects of peritoneal dialysis.Perit Dial Int2011; 31(Suppl 2): S73–6.
8.
SchilteM.N., CelieJ.W., WeeP.M., BeelenR.H., Van den BornJ.Factors contributing to peritoneal tissue remodeling in peritoneal dialysis.Perit Dial Int2009; 29: 605–17.
9.
FarhatK., StavenuiterA.W., BeelenR.H., Ter WeeP.M.Pharmacologic targets and peritoneal membrane remodeling.Perit Dial Int2014; 34: 114–23.
10.
JingS., KezhouY., HongZ., QunW., RongW.Effect of renin-angiotensin system inhibitors on prevention of peritoneal fibrosis in peritoneal dialysis patients.Nephrology2010; 15: 27–32.
11.
KolesnykI., NoordzijM., DekkerF.W., BoeschotenE.W., KredietR.T.A positive effect of AII inhibitors on peritoneal membrane function in long-term PD patients.Nephrol Dial Transplant2009; 24: 272–7.
12.
KolesnykI., DekkerF.W., NoordzijM., le CessieS., StruijkD.G., KredietR.T.Impact of ACE inhibitors and AII receptor blockers on peritoneal membrane transport characteristics in long-term peritoneal dialysis patients.Perit Dial Int2007; 27: 446–53.
13.
HueS.L., JoshiP., KaplanM., LefkovitzJ., PoenariuA., DworkinL.D.Rapid change in residual renal function decline is associated with lower survival and worse residual renal function preservation in peritoneal dialysis patients.Perit Dial Int2017; 37: 477–81.
14.
KendrickJ., TeitelbaumI.Strategies for improving long-term survival in peritoneal dialysis patients.Clin J Am Soc Nephrol2010; 5: 1123–31.
15.
FanS., DavenportA.Does loss of residual renal function lead to increased volume overload and hypertension in peritoneal dialysis patients?Perit Dial Int2015; 35(7): 753–5.
16.
TamP.Peritoneal dialysis and preservation of residual renal function.Perit Dial Int2009; 29(Suppl 2): S108–10.
17.
LiP.K., ChowK.M.Peritoneal dialysis-first policy made successful: perspectives and actions.Am J Kidney Dis2013; 62(5): 993–1005.
18.
Haag-WeberM.The impact of residual renal function on survival.Nephrol Dial Transplant2008; 23(7): 2123–6.
19.
SinnakirouchenanR., HolleyJ.L.Peritoneal dialysis versus hemodialysis: risks, benefits, and access issues.Adv Chronic Kidney Dis2011; 18(6): 428–32.
JohnsonD.W., ArmstrongK., CampbellS.B., MudgeD.W., HawleyC.M., CoombesJ.S.Metabolic syndrome in severe chronic kidney disease: prevalence, predictors, prognostic significance and effects of risk factor modification.Nephrology (Carlton)2007; 12(4): 391–8.
22.
GranthamC.E., HullK.L., Graham-BrownM.P.M., MarchD.S., BurtonJ.O.The potential cardiovascular benefits of low-glucose degradation product, biocompatible peritoneal dialysis fluids: a review of the literature.Perit Dial Int2017; 37(4): 375–83.
23.
WenY., GuoQ., YangX., WuX., FengS., TanJ.High glucose concentrations in peritoneal dialysate are associated with all-cause and cardiovascular disease mortality in continuous ambulatory peritoneal dialysis patients.Perit Dial Int2015; 35(1): 70–7.
24.
LiY., ZhangL., GuY., HaoC., ZhuT.Insulin resistance as a predictor of cardiovascular disease in patients on peritoneal dialysis.Perit Dial Int2013; 33(4): 411–8.
25.
Müller-KrebsS., KihmL.P., ZeierB., GrossM.L., WieslanderA., HaugU.Glucose degradation products result in cardiovascular toxicity in a rat model of renal failure.Perit Dial Int2010; 30(1): 35–40.
26.
FortesP.C., de MoraesT.P., MendesJ.G., StinghenA.E., RibeiroS.C., Pecoits-FilhoR.Insulin resistance and glucose homeostasis in peritoneal dialysis.Perit Dial Int2009; 29(Suppl 2): S145–8.
27.
ParkS.H., LindholmB.Definition of metabolic syndrome in peritoneal dialysis.Perit Dial Int2009; 29(Suppl 2): S137–44.
28.
García-LópezE., CarreroJ.J., SulimanM.E., LindholmB., StenvinkelP.Risk factors for cardiovascular disease in patients undergoing peritoneal dialysis.Perit Dial Int2007; 27(S2): S205–9.
29.
YongK., DograG., BoudvilleN., LimW.Increased inflammatory response in association with the initiation of hemodialysis compared with peritoneal dialysis in a prospective study of end-stage kidney disease patients.Perit Dial Int2018; 38(1): 18–23.
30.
IsoyamaN., MachowskaA., QureshiA.R., YamamotoT., AnderstamB., HeimburgerO.Elevated circulating S100A12 associates with vascular disease and worse clinical outcome in peritoneal dialysis patients.Perit Dial Int2016; 36(3): 269–76.
31.
Ramirez-SandovalJ.C., CasanovaI., VillarA., GomezF.E., CruzC., Correa-RotterR.Biomarkers associated with vascular calcification in peritoneal dialysis.Perit Dial Int2016; 36(3): 262–8.
32.
PuttaguntaH., HoltS.G.Peritoneal dialysis for heart failure.Perit Dial Int2015; 35(6): 645–9.
33.
WellsG.A., SheaB., O'ConnellD., PetersenJ., WelchV., LososM.The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomized studies in meta-analyses. [Online.] Available at: www.ohri.ca/programs/clinical_epidemiology/oxford.asp. Accessed 13 December 2018.
KimH., KimK.H., AhnS.V., KangS.W., YooT.H., AhnH.S.Risk of major cardiovascular events among incident dialysis patients: a Korean national population-based study.Int J Cardiol2015; 198: 95–101.
38.
LocatelliF., MarcelliD., ConteF., D'AmicoM., Del VecchioL., LimidoA.Survival and development of cardiovascular disease by modality of treatment in patients with end-stage renal disease.J Am Soc Nephrol2001; 12: 2411–7.
39.
Borràs SansM., Pérez-FontánM., Martinez-AlonsoM., BajoA., BetriuÀ., ValdivielsoJ.M.The modality of dialysis does not influence atheromatous vascular disease progression or cardiovascular outcomes in dialysis patients without previous cardiovascular disease.PLOS One2017; 12(11).
40.
OrtizA., CovicA., FliserD., FouqueD., GoldsmithD., KanbayM.Epidemiology, contributors to, and clinical trials of mortality risk in chronic kidney failure.Lancet2014; 383(9931): 1831–43.
41.
FoleyR.N.Comparing the incomparable: hemodialysis versus peritoneal dialysis in observational studies.Perit Dial Int2004; 24(3): 217–21.
42.
KorevaarJ.C., FeithG.W., DekkerF.W., Van ManenJ.G., BoeschotenE.W., BossuytP.M.; NECOSAD Study Group. Effect of starting with hemodialysis compared with peritoneal dialysis in patients new on dialysis treatment: a randomized controlled trial.Kidney Int2003; 64(6): 2222–8.
43.
CooperB.A., BranleyP., BulfoneL., CollinsJ.F., CraigJ.C., FraenkelM.B.; IDEAL Study. A randomized, controlled trial of early versus late initiation of dialysis.N Engl J Med2010; 363: 609–19.
